Related Experiment Video
Updated: Jul 1, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
FeBRILe3: Risk-Stratification and Diagnosis of Serious Bacterial Infections in Febrile Infants Less Than 3 Months Old
Ariel O Mace1,2,3, Jessica Ramsay3, James Totterdell4
1Department of General Paediatrics, Perth Children's Hospital, Perth, Western Australia, Australia.
Insights
A new guideline for fever without source (FWS) in infants showed high sensitivity for serious bacterial infections (SBIs) but low specificity. Further refinement is needed to improve prediction tools for infant fever management.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Epidemiology
- Risk Stratification
Background:
- Existing evidence-based recommendations support early discharge for low-risk infants with fever without source (FWS).
- Local context applicability of international data for FWS management remains a concern.
- A new risk-stratification guideline was implemented to address local needs.
Purpose of the Study:
- To describe the local epidemiology of FWS in young infants.
- To evaluate the performance of a newly implemented risk-stratification guideline for FWS.
- To support practice change in managing infants with FWS.
Main Methods:
- Prospective observational study of infants under 3 months with FWS.
- Two hospitals in Perth, Western Australia, participated from August 2019 to December 2021.
- Assessed guideline performance and determined likelihood ratios for patient characteristics predicting serious bacterial infections (SBIs).
Main Results:
- The cohort included 500 infants; 32% were diagnosed with SBIs (UTI, bacteremia, meningitis).
- The risk-stratification guideline showed 99% sensitivity and 97% negative predictive value for SBIs.
- Specificity was low (21%); female sex, sick contact, and virus detection reduced SBI likelihood.
Conclusions:
- The guideline effectively excluded most infants without SBIs but had limited predictive value for identifying low-risk infants.
- Additional patient characteristics are needed to enhance the accuracy of future risk-prediction tools.
- Refined algorithms can improve the management of fever without source in infants.
Objectives:
Evidence-based recommendations exist for early discharge (before 48 h) of young infants with fever without source (FWS) at low risk of serious bacterial infections (SBIs). However, concerns regarding the applicability of international data to local contexts may hinder implementation. We aimed to describe the local epidemiology of FWS and evaluate a newly implemented risk-stratification guideline to support practice change.
Methods:
Prospective observational study of infants aged < 3 months admitted for investigation and management of FWS to two hospitals in Perth, Western Australia following implementation of an FWS risk-stratification guideline (August 2019-December 2021). We assessed the risk-stratification rule performance and determined the positive/negative likelihood ratios of individual patient characteristics for predicting SBI diagnosis.
Results:
Five hundred infants were enrolled in the study cohort (median age 34 days, 36% female). SBI was diagnosed in 159 infants (32%), including urinary tract infection (n = 140), bacteraemia (n = 18) and bacterial meningitis (n = 9). Viruses were detected in 174 out of 406 tested infants (43%). Seventy-one infants met low-risk criteria (14%); only 69 out of 360 infants without SBI were classified as low risk (19%). The risk-stratification criteria demonstrated 99% sensitivity and 97% negative predictive value for SBI diagnosis, but only 21% specificity. Patient characteristics associated with a reduced likelihood of SBI diagnosis included female sex, sick contact exposure and virus detection.
Conclusions:
Meeting the low-risk criteria successfully excluded most infants with SBI; however, only a small proportion of infants without SBI fulfilled these criteria. Integrating additional patient characteristics into updated risk-stratification algorithms may improve the predictive value of future prediction tools.
Trial Registration:
Australia and New Zealand Clinical Trials Register (ACTRN12619001010189).
Related Concept Videos
Increased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Pneumonia III: Complications and Assessment
Acute Pyelonephritis II: Diagnostic Studies and Management
Rocky Mountain Spotted Fever
Bacterial Meningitis I: Introduction

